Active Ingredient(s): Busulfan
FDA Approved: * February 4, 1999
Pharm Company: * PDL BIOPHARMA INC
Category: Cancer

Busulfan (Myleran, GlaxoSmithKline, Busulfex IV, Otsuka America Pharmaceutical, Inc.) is a chemotherapy drug in use since 1959. It is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1,4-butanediol dimethanesulfonate. Contents 1 History 2 Indications 3 Availability 4 Side effects 5 Dosing, administration, and pharmacokinetics 6 Drug interactions 7 Pharmacology 8 Complexation 9 References 10 External links History B... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Busulfex 6 mg/ml Intravenous Injection
NDC: 59148-047
Otsuka America Pharmaceutical, Inc.
Busulfex 6 mg/ml Intravenous Injection
NDC: 59148-070
Otsuka America Pharmaceutical Inc.

Related Brands

Drugs with the same active ingredients